Nano Dentica, global commercialisation of bioactive fluorapatite
| Reference number | |
| Coordinator | Nano Dentica AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | September 2024 - April 2025 |
| Status | Completed |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Competence Enhancement in Small Businesses 2024 |
Important results from the project
The project achieved its goals of developing a market analysis and commercialization strategy for Nano Dentica’s bioactive fluorapatite, as well as supporting customer establishment. It resulted in new contacts and strengthened relationships with existing customers. Material has been distributed to additional customers for initial testing, and one customer is in the final stages of developing the first product containing Nano Dentica’s fluorapatite, with a regulatory processby the end of 2025.
Expected long term effects
The project has laid the foundation for Nano Dentica to position itself as a global player in bioactive materials for dental applications, with future potential in additional areas. The work has brought the company closer to commercial-scale production of fluorapatite and established a solid basis for future product launches through strategic customer engagement and a market entry plan, including pricing strategy and insights into regulatory requirements.
Approach and implementation
The project was carried out in close collaboration between Nano Dentica and Triathlon, with regular weekly check-ins and extended meetings and workshops when needed. Knowledge generated during the project was documented and resulted in a comprehensive market analysis. This analysis formed the basis for a go-to-market plan aimed at global commercialization. Customer establishment was also supported by Triathlon, both in identifying new potential partners and participating in meetings.